Haleon plc (NYSE:HLN) is one of the Best Young Stocks To Buy and Hold For 20 Year. On March 9, David Hayes from Jefferies maintained a Buy rating on Haleon plc (NYSE:HLN) with a p450.00 price target.

​The analyst maintained a bullish sentiment despite recent setbacks for the stock, citing that the drag from weaker cold and flu products in the fiscal fourth quarter of 2025 was unexpected. Regardless, the company maintained strong growth of more than 4% for the rest of its portfolio. The growth came despite US customers reducing excess inventory.

​Hayes noted that the management has pointed towards another cold and flu season headwind in fiscal Q1 2026. Despite the headwind, the firm expects the company to post 4% like‑for‑like growth. The firm noted that if Haleon can increase its underlying growth to 5% along with 9% growth in emerging markets, the company’s valuation will be well underpinned.

​Haleon (NYSE:HLN), together with its subsidiaries, researches, develops, manufactures, and sells various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

While we acknowledge the potential of HLN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.

Disclosure: None. Follow Insider Monkey on Google News.